Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Case of respiratory discomfort due to myositis after administration of nivolumab.

Literature DB >> 26104017

Case of respiratory discomfort due to myositis after administration of nivolumab.

Miri Yoshioka¹, Naotomo Kambe¹, Yosuke Yamamoto¹, Keisuke Suehiro¹, Hiroyuki Matsue¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2015 PMID： 26104017 DOI： 10.1111/1346-8138.12991

Source DB: PubMed Journal: J Dermatol ISSN： 0385-2407 Impact factor: 4.005

Keyword Cloud
Cited

× No keyword cloud information.

26 in total

1. Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab.

Authors: Laura C Cappelli; Anna Kristina Gutierrez; Alan N Baer; Jemima Albayda; Rebecca L Manno; Uzma Haque; Evan J Lipson; Karen B Bleich; Ami A Shah; Jarushka Naidoo; Julie R Brahmer; Dung Le; Clifton O Bingham
Journal: Ann Rheum Dis Date: 2016-06-15 Impact factor: 19.103

Review 2. Immune-Related Adverse Effects of Cancer Immunotherapy- Implications for Rheumatology.

Authors: Laura C Cappelli; Ami A Shah; Clifton O Bingham
Journal: Rheum Dis Clin North Am Date: 2016-10-22 Impact factor: 2.670

3. Statin Intolerance, Anti-HMGCR Antibodies, and Immune Checkpoint Inhibitor-Associated Myositis: A "Two-Hit" Autoimmune Toxicity or Clinical Predisposition?

Authors: Mitchell S von Itzstein; Shaheen Khan; Vinita Popat; Rong Lu; Saad A Khan; Farjana J Fattah; Jason Y Park; Bonnie L Bermas; David R Karp; Murtaza Ahmed; Jessica M Saltarski; Yvonne Gloria-McCutchen; Yang Xie; Quan-Zhen Li; Edward K Wakeland; David E Gerber
Journal: Oncologist Date: 2020-06-03

Review 4. Immune Checkpoint Inhibitor-Induced Myositis: a Case Report and Literature Review.

Authors: Hiroko Kadota; Takahisa Gono; Yuichiro Shirai; Yuka Okazaki; Mitsuhiro Takeno; Masataka Kuwana
Journal: Curr Rheumatol Rep Date: 2019-02-21 Impact factor: 4.592

Review 5. Rheumatic and Musculoskeletal Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature.

Authors: Laura C Cappelli; Anna Kristina Gutierrez; Clifton O Bingham; Ami A Shah
Journal: Arthritis Care Res (Hoboken) Date: 2017-09-21 Impact factor: 4.794

10. Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody.

Authors: Mehmet Asim Bilen; Sumit K Subudhi; Jianjun Gao; Nizar M Tannir; Shi-Ming Tu; Padmanee Sharma
Journal: J Immunother Cancer Date: 2016-06-21 Impact factor: 13.751

Case of respiratory discomfort due to myositis after administration of nivolumab.

1. Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab.

Review 2. Immune-Related Adverse Effects of Cancer Immunotherapy- Implications for Rheumatology.

3. Statin Intolerance, Anti-HMGCR Antibodies, and Immune Checkpoint Inhibitor-Associated Myositis: A "Two-Hit" Autoimmune Toxicity or Clinical Predisposition?

Review 4. Immune Checkpoint Inhibitor-Induced Myositis: a Case Report and Literature Review.

Review 5. Rheumatic and Musculoskeletal Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature.

Review 6. Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors.

Review 7. Cancer and autoimmunity: Harnessing longitudinal cohorts to probe the link.

8. Evaluation of Nivolumab for Ototoxic Effects: An Animal Study in Rats.

9. Nivolumab for the treatment of malignant melanoma in a patient with pre-existing myasthenia gravis.

10. Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody.